ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,690.44
      -0.41%
      US Tech 100
      19,212.00
      -0.63%
      Dow Jones
      41,962.56
      -0.15%
      Brent Oil
      74.025
      -0.40%
      Bitcoin
      62,789.75
      -0.25%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      09/17/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      09/13/20246:45AMGlobeNewswire Inc.Emergent BioSolutions Announces Agreement to Settle Securities Class Action LitigationNYSE:EBSEmergent Biosolutions Inc
      09/12/20248:30AMGlobeNewswire Inc.Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for EbolaNYSE:EBSEmergent Biosolutions Inc
      09/03/20247:47AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      09/03/20247:08AMGlobeNewswire Inc.Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial ProfileNYSE:EBSEmergent Biosolutions Inc
      08/30/20248:16AMGlobeNewswire Inc.Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency PreparednessNYSE:EBSEmergent Biosolutions Inc
      08/29/20246:53PMGlobeNewswire Inc.Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other RegionsNYSE:EBSEmergent Biosolutions Inc
      08/20/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      08/20/202411:30AMGlobeNewswire Inc.Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora PharmaceuticalsNYSE:EBSEmergent Biosolutions Inc
      08/19/20245:10PMGlobeNewswire Inc.Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in AfricaNYSE:EBSEmergent Biosolutions Inc
      08/06/20245:01PMGlobeNewswire Inc.Emergent BioSolutions Reports Second Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      08/06/20244:34PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
      08/06/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      08/06/20248:00AMGlobeNewswire Inc.Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the CountryNYSE:EBSEmergent Biosolutions Inc
      07/31/20248:56AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/31/20248:53AMGlobeNewswire Inc.Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 MillionNYSE:EBSEmergent Biosolutions Inc
      07/30/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/24/20247:30AMGlobeNewswire Inc.Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt SmithNYSE:EBSEmergent Biosolutions Inc
      07/23/20248:27AMGlobeNewswire Inc.Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024NYSE:EBSEmergent Biosolutions Inc
      07/22/20248:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in CanadaNYSE:EBSEmergent Biosolutions Inc
      07/12/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/12/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/10/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/09/20247:30AMGlobeNewswire Inc.Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation PlanNYSE:EBSEmergent Biosolutions Inc
      07/08/20244:57PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/02/20249:43AMGlobeNewswire Inc.Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure ProductsNYSE:EBSEmergent Biosolutions Inc
      07/02/20248:13AMGlobeNewswire Inc.Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure ProductsNYSE:EBSEmergent Biosolutions Inc
      06/20/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      06/20/20247:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 MillionNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS